
Dermatology experts discuss strategies to increase awareness of advances in AD in patients with SOC.

Dermatology experts discuss strategies to increase awareness of advances in AD in patients with SOC.

Drs. Neal Bhatia and Angela Lamb provide an overview of atopic dermatitis and its prevalence in patients with skin of color (SOC).

In this week’s Pointers with Dr Portela, the 208SkinDoc talks about how to overcome hormonal acne and other skin care tips.

Susan Taylor, MD, FAAD, compares how skin damage can occur in individuals with skin of color compared with individuals with light skin.

Susan Taylor, MD, FAAD, provides an overview of sun-caused skin damage.

At the SPD 2022 47th Annual Meeting, we chat with Albert Yan, MD, of Children's Hospital of Philadelphia on the latest trends in technology for pediatric dermatologists.

At an SPD 2022 47th Annual Meeting poster session, researchers look at gender and age differences in pediatric patients with melanoma.

At the SPD 2022 47th Annual Meeting, a poster session looks at the updated guidelines for rosacea, and whether they are inclusive of children.

At the SPD 2022 47th Annual Meeting, a recap of don’t-miss sessions for Sunday, July 10.

Amy Paller, MD, shares key takeaways from her session at the SPD 2022 47th Annual Meeting in Indianapolis.

At the SPD 2022 47th annual meeting, investigators share data on the treatment of ruxolitinib for this chronic autoimmune disease.

At the SPD 2022 47th Annual Meeting, researchers delve into the safety and practicality of using narrow-band UVB phototherapy on children with vitiligo.

At the SPD 2022 47th Annual Meeting, a discussion of the latest therapeutics for acne.

At the SPD 2022 47th Annual Meeting in Indianapolis, Indiana, Candrice Heath shares her takeaways "Atopic dermatitis in skin of color."

At the SPD 2022 47th Annual Meeting, a discussion of habitual skin and hair disorders in children and adolescents.

At the SPD 2022 47th Annual Meeting in Indianapolis, Candrice R. Heath, MD, FAAP, FAAD shares compelling best practices for treating patients of color with this condition.

Bernard A. Cohen, MD, shares what he thinks will be most exciting at this year's Society for Pediatric Dermatology Meeting in Indianapolis, Indiana.

Recent advances in technology have begun to allow the realization of personalized medicine in the practice of dermatology.

From pediatric dermatology quizzes to the latest news in telederm to practical pearls on atopic dermatitis, alopecia, and vitiligo, there’s a lot going on at the SPD 2022 47th Annual Meeting, this year in Indianapolis, Indiana.

Kenneth Gordon, MD, professor and chair of dermatology at the Medical College of Wisconsin, discusses new topical therapy treatment options for psoriasis and what he's looking forward to.

Melodie Young, MSN, A/GNP-C, nurse practitioner at Mindful Dermatology and a partner and sub-investigator with Modern Research Associates in Dallas, Texas, explains what NPs and PAs can bring to the dermatology space.

Meena Julapalli, MD, notes the sessions she is most looking forward to at the 2022 SPD 47th Annual Meeting in Indianapolis, Indiana.

Lawrence Eichenfield, MD, chief of pediatric and adolescent dermatology at Rady Children's Hospital-San Diego and professor of dermatology and pediatrics and vice-chair of the department of dermatology at UC San Diego School of Medicine, discusses new treatments and therapies for pediatric atopic dermatitis.

In this week’s Pointers with Dr Portela, the 208SkinDoc talks what a “summer rash” is and prevention.

Eric Simpson, MD, MCR, director of clinical research and dermatology professor at the Frances J. Storrs medical school at Oregon Health & Science University in Portland, Oregon, explains dives into what 2022 is bringing to the AD space.

Arthur Kavanaugh, MD, a professor of medicine and director of the Center for Innovative Therapy (CIT) at UC San Diego in California, gives his thoughts on the treatments for psoriatic arthritis, the comorbidities that have to be considered, and more.

Suneel Chilukuri, MD, director of Cosmetic Surgery at Refresh Dermatology in Houston, Texas, gives keys pearls on fillers and neuromodulators and what innovation is heading for the industry.

Arthur Kavanaugh, MD, a professor of medicine and director of the Center for Innovative Therapy (CIT) at UC San Diego in California, gives his thoughts on the future of psoriatic arthritis.

Suneel Chilukuri, MD, director of Cosmetic Surgery at Refresh Dermatology in Houston, Texas, explores potential international technology that may transform the injectable space.

Eric Simpson, MD, MCR, director of clinical research and dermatology professor at the Frances J. Storrs medical school at Oregon Health & Science University in Portland, Oregon, details the environment factors that could impact atopic dermatitis.